Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Rockville, Maryland
- Most recent report
- 6-K, filed Sep 8, 2026
- Filings on record
- 324 filings
- On EDGAR
- CIK 1778016
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer
Financials 8 of 170
- 6-K Report a foreign issuer made public elsewhere Sep 8, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 8, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 20, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 20, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 24, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 17, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 29, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 16, 2026
Prospectuses and Registrations 8 of 26
- S-8 Registration statement for an employee plan Aug 17, 2026
- 424B3 Prospectus supplement for an offering Oct 30, 2025
- S-8 Registration statement for an employee plan Sep 11, 2025
- 424B5 Prospectus supplement for an offering Aug 4, 2025
- 424B5 Prospectus supplement for an offering Jul 11, 2025
- F-3 May 2, 2025
- S-8 Registration statement for an employee plan May 30, 2024
- S-8 Registration statement for an employee plan Jun 17, 2022
Ownership 8 of 89
- 4 Insider reported a trade Sep 21, 2026
- 144 Notice of a proposed sale of restricted stock Sep 18, 2026
- 4 Insider reported a trade Sep 11, 2026
- 3 Insider reported their initial holding Sep 10, 2026
- 144 Notice of a proposed sale of restricted stock Sep 9, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 1, 2026
- 4 Insider reported a trade Aug 25, 2026
Other 8 of 39
- 20-F/A Annual report, foreign issuer, amended Jun 16, 2026
- 6-K/A Report a foreign issuer made public elsewhere, amended Feb 6, 2026
- 6-K/A Report a foreign issuer made public elsewhere, amended Oct 24, 2025
- F-6EF Aug 1, 2025
- 6-K/A Report a foreign issuer made public elsewhere, amended Jul 11, 2025
- EFFECT Notice that a registration became effective May 15, 2025
- UPLOAD Comment letter from SEC staff Aug 14, 2023
- CORRESP Reply to SEC staff Aug 7, 2023
Everything here comes from NovaBridge Biosciences's own filings on SEC EDGAR. The filing list is rechecked every hour.